Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
C.Morales-RullJ
doi: 10.1016/j.molcel.2023.10.043 198 LiuARSarkarNCressJDde JesusTJVadlakondaACentoreJTet al
A standard blood panel wont give you this information
Sustained Weight Loss: This weight loss attained through GLP-1 medications is maintained over the long term in some research studies
Proc Natl Acad Sci USA 2013
Key Research Features Dual-mechanism secretagogue blend GHRH + ghrelin receptor pathways CJC-1295 (No DAC): short half-life, pulsatile GH release profile Ipamorelin: selective GHS-R1a agonist, minimal cortisol/prolactin co-stimulation 99% HPLC-verified purity Identity confirmed for each component Lyophilized powder format Suitable for in vitro and preclinical research Batch-tested for consistency Research-grade manufacturing standards Professionally labeled and documented Storage Recommendations To maintain product stability and research integrity, CJC-1295 (No DAC) / Ipamorelin should be: Stored at 20C in a tightly sealed container Protected from light and moisture Reconstituted in sterile or bacteriostatic water Kept sealed until use Handled according to standard laboratory procedures Not subjected to repeated freeze-thaw cycles Toxicology and Regulatory Information Each component evaluated in preclinical endocrinology and secretagogue research models Ipamorelin characterized in research literature for selectivity no significant cortisol or prolactin co-stimulation reported CJC-1295 (No DAC) characterized for short-acting, pulsatile GH release profile without DAC-mediated receptor binding Supplied strictly as a Research Use Only (RUO) material Why Choose Summit Pep Labs
